Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI)

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Recruiting
CT.gov ID
NCT05649384
Collaborator
(none)
52,156
21
58
2483.6
42.9

Study Details

Study Description

Brief Summary

The PRESC1SE-MI study compares two algorithms for triage of patients presenting with chest pain and symptoms of heart attack (myocardial infarction) to the emergency department. Both algorithms are recommended by the European Society of Cardiology: the 0/3-hour algorithm and the 0/1-hour algorithm.

Currently, most emergency departments worldwide use the 0/3-hour troponin algorithm. Cardiac troponin (cTn) is a heart-specific biomarker which indicates damage of the heart muscle and which increases after a heart attack. In the 0/3-hour algorithm, the amount of troponin in the bloodstream is measured with a high-sensitivity assay at admission and 3 hours thereafter. Likewise, the 0/1-hour algorithm means that the blood sample in which the troponin is measured is collected at admission and 1 hour later. Since recent clinical studies suggest that the 0/1-hour algorithm is superior to the 0/3-hour algorithm, many hospitals consider switching to the 0/1-hour algorithm.

The aim of this study is to assess how feasible the time-saving 0/1-hour algorithm would be in reality and whether it provides the same accuracy and safety in the diagnosis of myocardial infarction as the current practice the 0/3-hour algorithm.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm
  • Diagnostic Test: European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm

Study Design

Study Type:
Observational
Anticipated Enrollment :
52156 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
PRospective Evaluation of the European Society of Cardiology 0/1-hour Algorithm's Safety and Efficacy for Triage of Patients With Suspected Myocardial Infarction (PRESC1SE-MI)
Actual Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Sep 30, 2025

Arms and Interventions

Arm Intervention/Treatment
0/1-hour algorithm

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.

Diagnostic Test: European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm
High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.
Other Names:
  • 0/1-hour algorithm
  • 0/3-hour algorithm

    High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.

    Diagnostic Test: European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm
    High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.
    Other Names:
  • 0/3-hour algorithm
  • Outcome Measures

    Primary Outcome Measures

    1. Composite of all-cause mortality or new AMI (type 1) occurring within 30 days of index presentation [30 days]

      Mortality rate and number of newly diagnosed AMI (type 1) in all enrolled patients

    2. Time from ED presentation to ED discharge or transfer [30 days]

      Length of stay in the ED measured in hours

    Secondary Outcome Measures

    1. Proportion of patients managed as outpatients [24 hours]

      Number of patients who stay in hospital for index event less than 24 hours

    2. Readmission for suspected AMI within 30 days after index presentation [30 days]

      Number of patients who stay in hospital for a new suspected AMI more than 24 hours within 30 days of index presentation

    3. All-cause mortality at 30 days in all patients [30 days]

      Number of deceased patients within 30 days after index presentation

    4. All-cause mortality at 365 days in all patients [365 days]

      Number of deceased patients within 365 days after index presentation

    5. New AMI (type1) at 30 days in all patients [30 days]

      Number of newly diagnosed AMI (type 1) in all patients within 30 days of index presentation

    6. New AMI (type 1) at 365 days in all patients [365 days]

      Number of newly diagnosed AMI (type 1) in all patients within 365 days of index presentation

    7. Composite of all-cause mortality or new AMI (type 1) at 365 days after index presentation [365 days]

      Mortality rate and number of newly diagnosed AMI (type 1) in all enrolled patients

    8. Satisfaction of patients with their evaluation in the ED [30 days]

      Satisfaction will be measured on a numerical/visual analogue scale from 0-100%, the higher the score, the greater the satisfaction

    9. Treatment costs in the ED [365 days]

      Costs of procedures performed in the ED will be calculated according to national remuneration systems

    10. Length of stay in the ED [30 days]

      Length of stay from admission to the ED to discharge or transfer will be calculated according to national remuneration systems

    11. Feasibility of the 0/1-hour algorithm [80 minutes]

      Feasibility defined as the percentage of patients in whom the "1h" blood draw is performed within 1h +/- 20 minutes from the "0h" blood draw

    12. Effectiveness of rule-in [30 days]

      Effectiveness defined as the time from presentation to coronary angiography in patients ultimately diagnosed with AMI (type 1)

    13. Effectiveness of rule-out [30 days]

      Effectiveness defined as time from presentation to discharge in patients ultimately diagnosed with non-cardiac disease

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients aged 18 and above

    • Presentation with acute non-traumatic acute chest pain to the emergency department

    • Suspicion of acute myocardial infarction

    Exclusion Criteria:
    • Terminal kidney failure requiring dialysis

    • Cardiac arrest

    • Cardiogenic shock

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Baylor St. Luke's Medical Center Houston Texas United States 77030
    2 St Andrew's War Memorial Hospital Brisbane Brisbane Australia
    3 Vienna General Hospital (AKH Wien) Wien Austria
    4 University Central Hospital Helsinki Helsinki Finland
    5 Attikon General Hospital Athens Athens Greece
    6 Careggi University Hospital Florence Florence Italy
    7 Azienda Ospedaliera San Giovanni Addolorata Roma Italy
    8 Hospital Città della Salute e della Scienza di Torino Torino Italy
    9 Konkuk University Medical Center Seoul Korea, Republic of
    10 Emergency Institute for Cardiovascular Diseases C.C. Iliescu Bucharest Romania
    11 Hospital Clinic Barcelona Barcelona Spain
    12 University Hospital October 12 Madrid Madrid Spain
    13 University Hospital Ramon y Cajal Madrid Spain
    14 Hospital Clínico Universitario Valencia Valencia Spain
    15 Kantonsspital Aarau Aarau Switzerland
    16 St. Claraspital Basel Switzerland
    17 Kantonsspital Luzern Luzern Switzerland
    18 University Hospital Zurich Zürich Switzerland
    19 Leicester Royal Infirmary Leicester United Kingdom LE1 5WW
    20 Royal London Hospital London United Kingdom
    21 Royal Cornwall Hospitals Treliske Truro United Kingdom

    Sponsors and Collaborators

    • University Hospital, Basel, Switzerland

    Investigators

    • Principal Investigator: Christian Müller, MD Prof., University Hospital, Basel, Switzerland
    • Principal Investigator: Jasper Boeddinghaus, MD, University Hospital, Basel, Switzerland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Basel, Switzerland
    ClinicalTrials.gov Identifier:
    NCT05649384
    Other Study ID Numbers:
    • 2019-02269
    First Posted:
    Dec 14, 2022
    Last Update Posted:
    Dec 14, 2022
    Last Verified:
    Dec 1, 2022

    Study Results

    No Results Posted as of Dec 14, 2022